Repeat LTBI testing best in patients taking biologics with new risk factorsDecember 9, 2019Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisLupus & Connective Tissue Diseases
Perioperative antirheumatic drug use does not impact postsurgery infection rate in RA patientsDecember 9, 2019Rheumatoid ArthritisMixed Topics
FDA approves infliximab-axxq for numerous indicationsDecember 6, 2019Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Certolizumab safety profile varies widely across indicationsNovember 27, 2019Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
More studies like VERVE needed to test live vaccines in special populationsNovember 25, 2019Rheumatoid ArthritisAnkylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
FDA announces approval of fifth adalimumab biosimilar, AbriladaNovember 18, 2019Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisPain
Biologic DMARDs appear as effective in elderly-onset RA as in young-onset RANovember 18, 2019Rheumatoid Arthritis
EHR treat-to-target prompts spur RA medication management decisionsNovember 12, 2019Rheumatoid Arthritis
Patients taking TNF inhibitors can safely receive Zostavax November 11, 2019Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitis
TNF level–based dosing of infliximab does not increase RA remission rateOctober 28, 2019Rheumatoid Arthritis
DNA methylation changes: An early biomarker for methotrexate response?October 18, 2019Rheumatoid Arthritis
Set reasonable expectations for managing refractory rheumatoid arthritisOctober 8, 2019Rheumatoid Arthritis
Consider centralized pain in patients with rheumatic diseaseOctober 8, 2019PainRheumatoid ArthritisOsteoarthritisLupus & Connective Tissue DiseasesSpondyloarthropathiesAnkylosing spondylitis
